(6aR,9R)-5-bromo-N-((2R,5S)-5-isobutyl-2-isopropyl-3,6-dioxo-3,5,6,8,9,10-hexahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide; 2-bromoanhydro-α-ergocryptine
Bromocriptine Impurity A (Mixture of Diastereomers) is a fully characterized chemical compound used as a reference standard of API Bromocriptine. The standard offered is compliant with regulatory guidelines. Bromocriptine Impurity A (Mixture of Diastereomers) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
